Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma.
Ben Arush
M W
MW
Department of Pediatric Hematology-Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. m_benarush@rambam.health.gov.il
Ben Itzhak
O
O
Yossilevski
G
G
El Hasid
R
R
Postovsky
S
S
Israel
O
O
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation; D002675:Child, Preschool; D018305:Ganglioneuroblastoma / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine